Inhibitory effects of tacrine and physostigmine on catecholamine secretion and membrane currents in guinea‐pig adrenal chromaffin cells

Summary— The effects of tacrine and physostigmine on catecholamine secretion induced by veratridine and high K+, and on voltage‐dependent Na+ and Ca2+ currents, were investigated in guinea‐pig adrenal chromaffin cells. In perfused adrenal glands, tacrine (100 μM) caused an inhibition of veratridine‐induced catecholamine secretion, but physostigmine (100 μM) did not. In dispersed cells, both tacrine (1 μM‐1 mM) and physostigmine (1 μM‐1 mM) decreased catecholamine secretion induced by veratridine in a dose‐dependent manner. The inhibitory effect of tacrine was much greater than that of physostigmine. Tacrine alone at a high concentration (such as 1 mM) caused a substantial increase in catecholamine secretion by itself and completely abolished the veratridine‐induced secretory response in dispersed cells. High‐concentration physostigmine showed a similar effect, but to a much lesser extent. The high K+ (46.2 mM)‐evoked catecholamine secretion from dispersed cells was not affected by tacrine (1–100 μM) or physostigmine (1 μM‐1 mM). In fura‐2 loaded cells, tacrine (100 μM) almost abolished [Ca2+]i rise induced by veratridine, but only slightly reduced that evoked by high K+. In voltage‐clamped cells, tacrine (300 μM) depressed the voltage‐dependent Na+ and Ca2+ currents by about 93% and 69%, and physostigmine (300 μM) depressed them by about 30% and 17%, respectively. These results suggest that tacrine decreases the veratridine‐induced catecholamine secretion primarily by inhibiting the voltage‐dependent Na+ channels rather than the Ca2+ channels. Physostigmine acts in a manner similar to tacrine, but its potency is much lower than that of tacrine.

[1]  S. Ito,et al.  Calcium channel subtypes in porcine adrenal chromaffin cells , 1997, Pflügers Archiv.

[2]  S. Ito,et al.  Tacrine inhibits nicotinic secretory and current responses in adrenal chromaffin cells. , 1997, European Journal of Pharmacology.

[3]  Manuela G. López,et al.  Q‐ and L‐type Ca2+ channels dominate the control of secretion in bovine chromaffin cells , 1994, FEBS letters.

[4]  M. Reuben,et al.  Blockade of nicotinic responses by physostigmine, tacrine and other cholinesterase inhibitors in rat striatum , 1994, British journal of pharmacology.

[5]  B. Sahakian,et al.  Tetrahydroaminoacridine (THA) in Alzheimer's disease: An assessment of attentional and mnemonic function using CANTAB , 1993, Acta neurologica Scandinavica. Supplementum.

[6]  C. Forray,et al.  Effects of tacrine on brain muscarinic-receptor-mediated second-messenger signals. , 1993, Pharmacology.

[7]  R. Gross,et al.  Tetrahydroaminoacridine (THA) reduces voltage-dependent calcium currents in rat sensory neurons , 1991, Neuroscience Letters.

[8]  E. El-Fakahany,et al.  Muscarinic subtype selectivity of tetrahydroaminoacridine: possible relationship to its capricious efficacy. , 1991, European journal of pharmacology.

[9]  D. Mash,et al.  Multiple in vitro interactions with and differential in vivo regulation of muscarinic receptor subtypes by tetrahydroaminoacridine. , 1989, The Journal of pharmacology and experimental therapeutics.

[10]  B. Winblad,et al.  Effects of THA on ionic currents in myelinated axons of Xenopus laevis. , 1989, European journal of pharmacology.

[11]  J. C. Lodder,et al.  9-Amino-1,2,3,4-tetrahydroacridine (THA), an alleged drug for the treatment of Alzheimer's disease, inhibits acetylcholinesterase activity and slow outward K+ current. , 1987, European journal of pharmacology.

[12]  A. Kling,et al.  Oral tetrahydroaminoacridine in long-term treatment of senile dementia, Alzheimer type. , 1986, The New England journal of medicine.

[13]  R. Tsien,et al.  Calcium rises abruptly and briefly throughout the cell at the onset of anaphase. , 1986, Science.

[14]  E. Albuquerque,et al.  The reversible cholinesterase inhibitor physostigmine has channel-blocking and agonist effects on the acetylcholine receptor-ion channel complex. , 1985, Molecular pharmacology.

[15]  R. Tsien,et al.  A new generation of Ca2+ indicators with greatly improved fluorescence properties. , 1985, The Journal of biological chemistry.

[16]  B. Livett,et al.  Biphasic Effect of Eserine and Other Acetylcholinesterase Inhibitors on the Nicotinic Response to Acetylcholine in Cultured Adrenal Chromaffin Cells , 1982, Journal of neurochemistry.

[17]  S. Ito,et al.  EXOCYTOTIC RELEASE OF CATECHOLAMINE FROM PERFUSED ADRENAL GLAND OF GUINEA‐PIG INDUCED BY VERATRIDINE , 1980, British journal of pharmacology.

[18]  Y. Nakazato,et al.  THE EFFECT OF VERATRIDINE ON THE RELEASE OF CATECHOLAMINES FROM THE PERFUSED ADRENAL GLAND , 1979, British journal of pharmacology.

[19]  J. Hochman,et al.  Catecholamine secretion by isolated adrenal cells. , 1976, Biochimica et biophysica acta.

[20]  A. Maelicke,et al.  A novel agonist binding site on nicotinic acetylcholine receptors. , 1993, Journal of receptor research.

[21]  A. Kling,et al.  Oral tetrahydroaminoacridine in long-term treatment of senile dementia, Alzheimer??s type , 1987 .

[22]  M. Ota,et al.  Effects of veratrum alkaloids on membrane potential and conductance of squid and crayfish giant axons. , 1973, The Journal of pharmacology and experimental therapeutics.